Elite Pharmaceuticals, Inc. Stock Issued During Period, Shares, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Elite Pharmaceuticals, Inc. stock issued during period, shares, other for fiscal 2024 was 54.36M shares, a 1964.42% increase from fiscal 2023.
- Elite Pharmaceuticals, Inc. stock issued during period, shares, other for fiscal 2023 was 2.63M shares.
| Period end | Stock Issued During Period, Shares, Other 3 month | Stock Issued During Period, Shares, Other 12 month |
|---|---|---|
| 2024-03-31 | 54.36M shares 10-K · filed 2024-07-01 | |
| 2023-03-31 | 2.63M shares 10-K · filed 2024-07-01 |